temozolomide has been researched along with Lung Adenocarcinoma in 3 studies
Excerpt | Relevance | Reference |
---|---|---|
" The efficacy was significantly improved after lobaplatin combined with pemetrexed, temozolomide and bevacizumab." | 1.56 | Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR-ANXA2, EGFR-RAD51, ATR and BRCA2 mutations: A case report. ( Cheng, Y; Huang, Z; Li, H; Liu, J; Liu, Y; Zhang, S; Zhong, R, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Zhong, R | 1 |
Li, H | 1 |
Liu, Y | 1 |
Zhang, S | 1 |
Liu, J | 1 |
Huang, Z | 1 |
Cheng, Y | 1 |
Yang, Y | 1 |
Pu, Y | 1 |
Dai, N | 1 |
Wang, D | 1 |
Xu, M | 1 |
Leng, S | 1 |
Bernauer, AM | 1 |
Hong, C | 1 |
Do, KC | 1 |
Yingling, CM | 1 |
Flores, KG | 1 |
Tessema, M | 1 |
Tellez, CS | 1 |
Willink, RP | 1 |
Burki, EA | 1 |
Picchi, MA | 1 |
Stidley, CA | 1 |
Prados, MD | 1 |
Costello, JF | 1 |
Gilliland, FD | 1 |
Crowell, RE | 1 |
Belinsky, SA | 1 |
3 other studies available for temozolomide and Lung Adenocarcinoma
Article | Year |
---|---|
Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR-ANXA2, EGFR-RAD51, ATR and BRCA2 mutations: A case report.
Topics: Adenocarcinoma of Lung; Adult; Annexin A2; Antineoplastic Combined Chemotherapy Protocols; Ataxia Te | 2020 |
Complete response of radioresistant brain metastases from non-small cell lung cancer with temozolomide: A case report and literature review.
Topics: Adenocarcinoma of Lung; Antineoplastic Agents, Alkylating; Brain Neoplasms; Female; Humans; Lung Neo | 2020 |
The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Antineoplastic Agents, Alkylating; beta-Galacto | 2011 |